Report : South and Central America Infertility Treatment Devices and Equipment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Ovum Aspiration Pumps, Sperm Separation Devices, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, and Others); Procedure (Assisted Reproductive Technology, Artificial Insemination, and Fertility Surgery); End User (Fertility Clinics, Hospitals and Other Healthcare Facilities, and Clinical Research Institutes) and Country
Fertility Clinics Segment Held Largest Share of End User in South & Central America Infertility Treatment Devices and Equipment Market in 2019
According to a new market research study of ‘South & Central America Infertility Treatment Devices and Equipment Market Forecast to 2027 - COVID-19 Impact and Analysis by product, procedure, and end-user’ the South & Central America infertility treatment devices and equipment market is expected to reach US$ 108.35 million in 2027 from US$ 62.69 in 2019. The market is estimated to grow with a CAGR of 7.2% from 2020-2027. The report provides trends prevailing in the South & Central America infertility treatment devices and equipment market and the factors driving market along with those that act as hindrances.
Based on the end user, the South & Central America the infertility treatment devices and equipment market, is segmented into fertility clinics, hospitals and other healthcare facilities, and clinical research institutes. The fertility clinics segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. The global health system is witnessing considerable spending on the infertility treatments. For instance, according to a data published in IMTJ (International Medical Travel Journal) in April 2019, Chinese couple spend around US$ 8.0 BN each year on in-vitro fertilization. This extensively growing spending on treatments generates lucrative opportunity for new fertility centers across the globe. In April 2019, Manson Group, a Hong Kong based fertility services provider announced its plan to open offshore fertility centers for Chinese couples. In addition, the fertility services providers are focusing on the implementation of in-organic strategies such as partnerships and acquisitions to expand the boundaries of business operations. For instance, in July 2020, Spring Fertility, a US-based collaborated with Genesis Fertility Centre, a Canada-based fertility services provider. Such activities are estimated to have positive impact on the growth of the fertility centers segment growth during the forecast period.
The growth of this market is estimated to grow owing to key driving factors such as a high rise in the infertility rate and increased support by the government to promote fertility. However, lack of national regulatory bodies and stringent societal norms are likely to hamper the market growth.
Vitrolife, INVO Bioscience, and Eppendorf AG are among the leading companies operating in the South & Central America infertility treatment devices and equipment market.
South & Central America Infertility Treatment Devices and Equipment Market, By Country, 2019 (% share)
The report segments South & Central America Infertility Treatment Devices and Equipment Market as Follows:
- Ovum Aspiration Pumps
- Sperm Separation Devices
- Sperm Analyzer Systems
- Micromanipulator Systems
- Incubators
- Others
- Assisted Reproductive Technology
- In Vitro Fertilization
- Intracytoplasmic Sperm Injection
- Others
- Artificial Insemination
- Intrauterine Insemination
- Intratubal Insemination
- Intracervical Insemination
- Fertility Surgery
- Tubal Ligation Reversal
- Varicocelectomy
- Laparoscopy
- Others
- Fertility Clinics
- Hospitals and Other Healthcare Facilities
- Clinical Research Institutes
- South & Central America
- Brazil
- Argentina